Desk› Healthcare› Dipna Pharmachem Ltd

Dipna Pharmachem Ltd

BSE 543594 DPL INE0MC401013

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

13 filings · 6 material · busiest 2026-07-02

What it files

Resignation2 Board Outcome2 Compliance Certificate1 Newspaper Publication1 Outcome1 Change in Directorate1 Results1 Other Update1

Filings

13 in the window

15 July 2026

Compliance Certificate

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Submission of Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended on 30th June, 2026

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
6 July 2026

Newspaper Publication

Newspaper Publication

Announcement under Regulation 30 (LODR) - Newspaper Publication

Company Update / Newspaper Publication View filing →
2 July 2026

Outcome

543594 - Board Meeting Outcome for Outcome And Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Outcome and Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Others / Outcome without intimation View filing →
2 July 2026

Change in Directorate

Change in Directorate

Announcement under Regulation 30 (LODR) - Change in Directorate

Company Update / Change in Directorate View filing →
2 July 2026

Resignation

Resignation of Director

Announcement under Regulation 30 (LODR) - Resignation of Director

Company Update / Resignation of Director View filing →
2 July 2026

Resignation

Resignation of Director

Announcement under Regulation 30 (LODR) - Resignation of Director

Company Update / Resignation of Director View filing →
2 July 2026

Board Outcome

Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 2Nd July, 2026

Outcome of Board Meeting held today i.e. 2nd July, 2026

Board Meeting / Outcome of Board Meeting View filing →
2 July 2026

Results

Submission Of Financial Results

Submission of Financial Results

Result / Financial Results View filing →
2 July 2026

Other Update

Submission Of Statement Of Deviation And Variation

Submission of Statment of Deviation and Variation

Company Update / Reg. 32 (1), (3) - Statement of Deviation & Variation View filing →
2 July 2026

General

Submission Of Integrated Financials

Submission of Integrated Financials

Company Update / General View filing →
1 July 2026

Board Meeting

Board Meeting Intimation for Outcome And Intimation For Rescheduling Of Board Meeting To 2Nd July, 2026

Dipna Pharmachem Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/07/2026 ,inter alia, to consider and approve Outcome and Intimation for ....

Company Update / Board Meeting Rescheduled View filing →
1 July 2026

Board Outcome

Board Meeting Outcome for Outcome And Intimation For Rescheduling Of Board Meeting To 2Nd July, 2026

Outcome and Intimation for Rescheduling of Board Meeting to 2nd July, 2026

Board Meeting / Outcome of Board Meeting View filing →
30 June 2026

Trading Window

Closure of Trading Window

Intimation of Closure of Trading Window

Insider Trading / SAST / Closure of Trading Window View filing →